These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20425372)

  • 1. Rituximab maintenance therapy in follicular lymphoma.
    Forstpointner R; Dreyling M
    Curr Hematol Malig Rep; 2007 Oct; 2(4):213-8. PubMed ID: 20425372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab maintenance versus retreatment in follicular lymphoma.
    Palla AR; Hamadani M
    Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.
    Wrench D; Montoto S
    Nat Rev Clin Oncol; 2010 Dec; 7(12):677-8. PubMed ID: 21116237
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.
    Arcaini L; Montanari F; Alessandrino EP; Tucci A; Brusamolino E; Gargantini L; Cairoli R; Bernasconi P; Passamonti F; Bonfichi M; Zoli V; Bottelli C; Calatroni S; Troletti D; Merli M; Pascutto C; Majolino I; Rossi G; Morra E; Lazzarino M
    Ann Oncol; 2008 Jul; 19(7):1331-1335. PubMed ID: 18344536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
    Vidal L; Gafter-Gvili A; Leibovici L; Dreyling M; Ghielmini M; Hsu Schmitz SF; Cohen A; Shpilberg O
    J Natl Cancer Inst; 2009 Feb; 101(4):248-55. PubMed ID: 19211444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon: does it still have a role in the 21st century?
    McLaughlin P; Sacchi S
    Leuk Lymphoma; 2009 Oct; 50(10):1562-3. PubMed ID: 19863334
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
    Seymour JF
    Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
    Seiler T; Hiddemann W; Dreyling M
    Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study.
    Jäeger G; Neumeister P; Brezinschek R; Höfler G; Quehenberger F; Linkesch W; Sill H
    Eur J Haematol; 2002 Jul; 69(1):21-6. PubMed ID: 12270058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-occurrence of the CD20 molecule expression subsequent to CD20-negative relapse in diffuse large B-cell lymphoma.
    Ferreri AJ; Dognini GP; Verona C; Patriarca C; Doglioni C; Ponzoni M
    Haematologica; 2007 Jan; 92(1):e1-2. PubMed ID: 17405748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD20 monoclonal antibody (rituximab) for therapy of CD20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl.
    Culić S; Armanda V; Kuljis D; Kuzmic I; Pranic-Kragic A; Jankovic S
    Pediatr Hematol Oncol; 2006 Dec; 23(8):661-6. PubMed ID: 17065142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in indolent lymphomas.
    Sousou T; Friedberg J
    Semin Hematol; 2010 Apr; 47(2):133-42. PubMed ID: 20350660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
    Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of rituximab in patients with follicular lymphoma.
    Marcus R
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):38-49. PubMed ID: 17305253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.
    van Oers MH; Van Glabbeke M; Giurgea L; Klasa R; Marcus RE; Wolf M; Kimby E; van t Veer M; Vranovsky A; Holte H; Hagenbeek A
    J Clin Oncol; 2010 Jun; 28(17):2853-8. PubMed ID: 20439641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for follicular non-Hodgkin lymphoma.
    Gajraj E; Chung H; Longson C; Stevens A
    Lancet Oncol; 2008 Apr; 9(4):320-1. PubMed ID: 18405852
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonmyeloablative stem cell transplantation in follicular B-cell lymphoma.
    Tam CS; Khouri I
    Curr Hematol Malig Rep; 2007 Oct; 2(4):225-31. PubMed ID: 20425374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy followed by autologous and allogeneic hematopoietic stem cell transplantation in patients with follicular non-Hodgkin’s lymphoma in the rituximab era.
    Escobar IG; Sánchez de Ibarguen BC; de Juan VC; Alonso CM; García MM; Ruíz AC; Pulla MP
    Tumori; 2015; 101(1):2-7. PubMed ID: 25702654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.